SNL Sketch Exposes the Absurd Disconnect of Online Realities
A recent SNL sketch skillfully highlights how personalized algorithms can distort our perceptions and connections in real life.
October 04, 2026
Lifestyle
Lifestyle trends and health tips
NIH Unveils Revamped Website for Enhanced Access to Health Research Information
The NIH is launching a new website design focused on core themes to simplify public access to health and biomedical research information.
October 02, 2026
Anticipating the Nobel Prize: Insights from Mary-Claire King on Recognition and Legacy
Mary-Claire King shares her experience and thoughts on the impact of her work amidst the suspense of the Nobel Prize anticipation.
October 02, 2026
Challenges Persist in Retaining Young People in Opioid Addiction Treatment
Despite increased access to addiction medications for youth, retention remains alarmingly low, raising urgent concerns among healthcare professionals.
October 02, 2026
NIH Faces Criticism Over Grant Distribution and Delays in Research Funding
NIH's fiscal year 2026 grant distribution raises concerns among researchers due to delays and a decline in project funding.
October 02, 2026
Medicare Advantage Plans Face Increased Costs and Reduced Benefits in 2027
Enrollees in Medicare Advantage plans for 2027 need to prepare for higher out-of-pocket expenses and fewer benefits during the upcoming enrollment period.
October 01, 2026
New Perspectives on Women's Health: A Closer Look at Menopause and Pain
A recent special issue of Science highlights the need for more research in women's health, particularly on menopause, pain mechanisms, and beyond.
October 01, 2026
Blue Shield of California Plans to Implement Medicare-Inspired Payment Models by 2027
Blue Shield of California aims to adopt Medicare-inspired payment models, enhancing care for six million members by 2027.
October 01, 2026
Huntington's Advocate Responds to UniQure's Latest Gene Therapy Results
Despite a decline in effectiveness, Huntington's patient Lauren Holder remains optimistic about UniQure's gene therapy for slowing disease progression.
October 01, 2026
Understanding the Rise of GLP-1 Prescriptions for Children with Obesity
A significant surge in GLP-1 prescriptions for children highlights a growing response to childhood obesity and its medical implications.
October 01, 2026
China's Biotech Sector Champions Efficiency Amid Global Competition
Biotech leaders in Shanghai tout rapid drug development in China, positioning themselves as a competitive force against Western markets.
October 01, 2026
Can Eric Cantor Revitalize Pharma's Image Among Voters?
Eric Cantor seeks to reshape the pharmaceutical industry's image and policies to align with voter concerns, revisiting past strategies aimed at broader public appeal.
October 01, 2026
Study Reveals Lingering Health Risks from Toxic Metals Post-Wildfires in Maui
Research highlights the long-term respiratory risks posed by toxic metals from the 2023 Maui wildfires, persisting even after the flames have subsided.
September 28, 2026
Merck Halts U.S. Supply of Recarbrio Amid Antibiotic Resistance Concerns
Merck's recent decision to discontinue Recarbrio raises questions about the pharmaceutical industry's commitment to tackling antibiotic resistance.
September 28, 2026
The Dire Future of Employer-Sponsored Health Insurance
The outlook for employer-sponsored health insurance is grim, with experts predicting even higher costs in 2027, as recent trends worsen the situation.
September 28, 2026
Shifting Strategies: GLP-1s Marketed as Lifestyle Enhancements Amid Setbacks for Merck and Daiichi
GLP-1 drugs are now being marketed for general wellness rather than just obesity, while Merck and Daiichi face setbacks in cancer therapy approval.
September 28, 2026
Novo Nordisk's GLP-1s: Bridging Medical and Lifestyle Drug Categories
Novo Nordisk blurs the line between medications and lifestyle enhancements with its GLP-1s, sparking debate over their true classification.
September 28, 2026
GLP-1 Drugs Transition from Medical Solutions to Lifestyle Enhancements
GLP-1 medications are shifting focus from medical obesity treatments to lifestyle products, reflecting a broader marketing strategy by companies like Novo Nordisk.
September 28, 2026
AI's Dual-Use Dilemma: The Fine Line Between Medical Research and Bioweapons
Recent cases reveal how AI technology can unintentionally facilitate bioweapons development, blurring the lines of scientific intent.
September 28, 2026
Uncovering New Insights in Cardiac Anatomy Through Observation
A recent discovery in the anatomy of the heart challenges established knowledge, revealing a previously unrecognized structure and its implications for stroke risk.
September 28, 2026